how to get glp-1 agonists Receptor Explained for Pharmacy & Medical Students: Mechanism, Uses, and Side Effects Evolution of GLP‐1 Receptor Agonists

DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling

Great summary of emerging GLP-1 medicines including: triple agonist retatrutide maridebart cafraglutide (MariTide), a long-acting peptide-antibody conjugate that combines GLP-1 receptor agonism with GIP receptor antagonism Amycretin, a unimolecular GLP-1 and amylin receptor agonist, CagriSema - a fixed-dose, once-weekly combination of semaglutide and the long-acting amylin analogue cagrilintide Oral formulations of GLP-1 medicines including orforglipron Fixed-dose combinations of GLP-1 receptor agonists and basal insulin Emerging Indications such as: cardiovascular disease in patients with obesity without diabetes based on the SELECT trial metabolic liver disease based on the ESSENCE trial peripheral artery disease based on STRIDE trial potential indications such as Parkinson disease and dementia Nice summary on muscle loss and muscle composition Great paper

The axis represents time in weeks

Richard JE, Anderberg RH, Gteson A, Gribble FM, Reimann F, Skibicka KP

GLP-1 receptors are expressed in reward-related regions, such as the nucleus accumbens (NAc) and ventral tegmental area (VTA), where they influence dopaminergic signaling [43]